CK Life Sciences Int'l. (Holdings) Balance Sheet Health
Financial Health criteria checks 0/6
CK Life Sciences Int'l. (Holdings) has a total shareholder equity of HK$4.0B and total debt of HK$5.5B, which brings its debt-to-equity ratio to 136.3%. Its total assets and total liabilities are HK$10.9B and HK$6.9B respectively. CK Life Sciences Int'l. (Holdings)'s EBIT is HK$252.4M making its interest coverage ratio 0.7. It has cash and short-term investments of HK$562.1M.
Key information
136.3%
Debt to equity ratio
HK$5.47b
Debt
| Interest coverage ratio | 0.7x |
| Cash | HK$562.09m |
| Equity | HK$4.01b |
| Total liabilities | HK$6.87b |
| Total assets | HK$10.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LSI's short term assets (HK$2.8B) do not cover its short term liabilities (HK$2.9B).
Long Term Liabilities: LSI's short term assets (HK$2.8B) do not cover its long term liabilities (HK$4.0B).
Debt to Equity History and Analysis
Debt Level: LSI's net debt to equity ratio (122.3%) is considered high.
Reducing Debt: LSI's debt to equity ratio has increased from 111.2% to 136.3% over the past 5 years.
Debt Coverage: LSI's debt is not well covered by operating cash flow (10.6%).
Interest Coverage: LSI's interest payments on its debt are not well covered by EBIT (0.7x coverage).